GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annovis Bio Inc (FRA:07X) » Definitions » Beginning Cash Position

Annovis Bio (FRA:07X) Beginning Cash Position : €3.60 Mil (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Annovis Bio Beginning Cash Position?

Annovis Bio's Beginning Cash Position for the quarter that ended in Sep. 2024 was €3.60 Mil.

Annovis Bio's quarterly Beginning Cash Position declined from Mar. 2024 (€5.29 Mil) to Jun. 2024 (€2.91 Mil) but then increased from Jun. 2024 (€2.91 Mil) to Sep. 2024 (€3.60 Mil).

Annovis Bio's annual Beginning Cash Position increased from Dec. 2021 (€7.15 Mil) to Dec. 2022 (€43.13 Mil) but then declined from Dec. 2022 (€43.13 Mil) to Dec. 2023 (€26.02 Mil).


Annovis Bio Beginning Cash Position Historical Data

The historical data trend for Annovis Bio's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Annovis Bio Beginning Cash Position Chart

Annovis Bio Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial 0.03 - 7.15 43.13 26.02

Annovis Bio Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.74 5.83 5.29 2.91 3.60

Annovis Bio Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Annovis Bio Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Annovis Bio's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Annovis Bio Business Description

Traded in Other Exchanges
Address
101 Lindenwood Drive, Suite 225, Malvern, PA, USA, 19355
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

Annovis Bio Headlines

No Headlines